AU2004308757B2 - Assembly of gas-filled microvesicle with active component for contrast imaging - Google Patents

Assembly of gas-filled microvesicle with active component for contrast imaging

Info

Publication number
AU2004308757B2
AU2004308757B2 AU2004308757A AU2004308757A AU2004308757B2 AU 2004308757 B2 AU2004308757 B2 AU 2004308757B2 AU 2004308757 A AU2004308757 A AU 2004308757A AU 2004308757 A AU2004308757 A AU 2004308757A AU 2004308757 B2 AU2004308757 B2 AU 2004308757B2
Authority
AU
Australia
Prior art keywords
assembly
gas
active component
contrast imaging
filled microvesicle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2004308757A
Other languages
English (en)
Other versions
AU2004308757A1 (en
Inventor
Philippe Bussat
Michel Schneider
Anne Senente
Feng Yan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bracco Suisse SA
Original Assignee
Bracco Suisse SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Suisse SA filed Critical Bracco Suisse SA
Publication of AU2004308757A1 publication Critical patent/AU2004308757A1/en
Application granted granted Critical
Publication of AU2004308757B2 publication Critical patent/AU2004308757B2/en
Assigned to BRACCO SUISSE S.A. reassignment BRACCO SUISSE S.A. Request to Amend Deed and Register Assignors: BRACCO RESEARCH SA
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6925—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/225—Microparticles, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acoustics & Sound (AREA)
  • Engineering & Computer Science (AREA)
  • Radiology & Medical Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
AU2004308757A 2003-12-22 2004-12-21 Assembly of gas-filled microvesicle with active component for contrast imaging Ceased AU2004308757B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03079014.1 2003-12-22
EP03079014 2003-12-22
PCT/IB2004/004233 WO2005063306A1 (en) 2003-12-22 2004-12-21 Assembly of gas-filled microvesicle with active component for contrast imaging

Publications (2)

Publication Number Publication Date
AU2004308757A1 AU2004308757A1 (en) 2005-07-14
AU2004308757B2 true AU2004308757B2 (en) 2010-06-17

Family

ID=34717205

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004308757A Ceased AU2004308757B2 (en) 2003-12-22 2004-12-21 Assembly of gas-filled microvesicle with active component for contrast imaging

Country Status (9)

Country Link
US (2) US20070081946A1 (enExample)
EP (1) EP1696965B1 (enExample)
JP (1) JP2007515471A (enExample)
CN (1) CN1897978B (enExample)
AU (1) AU2004308757B2 (enExample)
CA (1) CA2545362C (enExample)
ES (1) ES2531751T3 (enExample)
NO (1) NO338317B1 (enExample)
WO (1) WO2005063306A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004210221B2 (en) 2003-02-04 2008-11-20 Bracco Suisse S.A. Ultrasound contrast agents and process for the preparation thereof
CN100563718C (zh) * 2003-12-22 2009-12-02 伯拉考开发股份有限公司 用于反差成像的充气微囊组件
CN1909931B (zh) * 2004-01-15 2011-01-12 皇家飞利浦电子股份有限公司 用于分子成像的超声造影剂
EP1784228B1 (en) 2004-08-18 2016-10-05 Bracco Suisse SA Gas-filled microvesicles composition for contrast imaging
US7651770B2 (en) * 2005-12-16 2010-01-26 The University Of Kansas Nanoclusters for delivery of therapeutics
WO2008028917A1 (en) 2006-09-05 2008-03-13 Bracco Research Sa Gas-filled microvesicles with polymer-modified lipids
US20100041989A1 (en) * 2006-09-29 2010-02-18 The Trustees Of The University Of Pennsylvania Use of ultrasound as an antivascular agent
US20090234231A1 (en) * 2008-03-13 2009-09-17 Knight Jon M Imaging Catheter With Integrated Contrast Agent Injector
GB0811856D0 (en) 2008-06-27 2008-07-30 Ucl Business Plc Magnetic microbubbles, methods of preparing them and their uses
EP2346532B1 (en) 2008-10-07 2020-10-07 Bracco Suisse SA Targeting construct comprising anti-polymer antibody and microvesicles binding to the same
PL2355851T3 (pl) 2008-11-10 2018-08-31 Arbutus Biopharma Corporation Nowe lipidy i kompozycje do dostarczania środków terapeutycznych
EP2398503B1 (en) 2009-02-13 2018-10-31 University Of Washington Gadolinium expressed lipid nanoparticles for magnetic resonance imaging
EP2253308A1 (en) 2009-05-22 2010-11-24 Ludwig-Maximilians-Universität München Pharmaceutical composition comprising microbubbles for targeted tumor therapy
WO2011017524A1 (en) * 2009-08-05 2011-02-10 The Trustees Of The University Of Pennsylvania Microfluidic-based generation of functionalized microbubbles for ultrasound imaging and therapy
WO2011025893A1 (en) 2009-08-28 2011-03-03 The Trustees Of Columbia University In The City Of New York Systems, methods, and devices for production of gas-filled microbubbles
WO2011035254A1 (en) * 2009-09-21 2011-03-24 Drexel University Stabilized ultrasound contrast agent
WO2011091160A1 (en) * 2010-01-20 2011-07-28 Henry Wu Custom-formulated phospholipid microbubbles and methods and uses thereof
US9265483B2 (en) 2010-08-06 2016-02-23 The Trustees Of Columbia University In The City Of New York Medical imaging contrast devices, methods, and systems
TW201208706A (en) 2010-08-17 2012-03-01 Univ Nat Yang Ming Ultrasonically-triggered drug vehicle with magnetic resonance imaging function
KR101292939B1 (ko) * 2010-12-31 2013-08-02 삼성전자주식회사 엠알유도 고강도집속초음파 치료 및 진단용 인지질 나노입자 및 이의 제조방법
JP6313329B2 (ja) 2012-12-21 2018-04-18 ブラッコ・スイス・ソシエテ・アノニムＢｒａｃｃｏ Ｓｕｉｓｓｅ ＳＡ ガス封入マイクロベシクル
HUE060034T2 (hu) * 2013-09-27 2023-01-28 Exact Therapeutics As Ultrahanggal közvetített hatóanyag leadás
JP6202563B2 (ja) * 2013-10-21 2017-09-27 ネッパジーン株式会社 負電荷バブルリポソーム及びカチオン性ペプチドからなる薬物送達キャリア
KR101595795B1 (ko) * 2014-03-19 2016-02-22 (주)아이엠지티 약물을 함유한 나노입자가 결합된 이중-목적 paｔ／초음파 조영제 및 이의 제조방법
CN111836650B (zh) * 2018-03-07 2024-06-18 博莱科瑞士股份有限公司 尺寸可控微泡的制备
EP3897954B1 (en) * 2018-12-21 2024-05-01 Bracco Suisse SA Gas-filled microvesicles with ligand
GB2595513B (en) * 2020-05-29 2023-03-29 Act Therapeutics Ltd Treatment of infections
CN117479962A (zh) * 2021-07-14 2024-01-30 博莱科瑞士股份有限公司 阳离子标准化尺寸充气微泡
WO2024059715A2 (en) * 2022-09-14 2024-03-21 Drexel University Microbubbles and methods of making same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995023615A1 (en) * 1994-03-01 1995-09-08 Holmes, Michael, John Gas-containing microcapsules useful as contrast agents for diagnostic imaging
US5562099A (en) * 1990-10-05 1996-10-08 Massachusetts Institute Of Technology Polymeric microparticles containing agents for imaging
US6331289B1 (en) * 1996-10-28 2001-12-18 Nycomed Imaging As Targeted diagnostic/therapeutic agents having more than one different vectors

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276885A (en) * 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
DE3581471D1 (de) * 1984-10-19 1991-02-28 Battelle Memorial Institute Durch mikroorganismen abbaubares polypeptid und seine verwendung fuer die fortschreitende abgabe von medikamenten.
IN172208B (enExample) * 1990-04-02 1993-05-01 Sint Sa
US5556610A (en) * 1992-01-24 1996-09-17 Bracco Research S.A. Gas mixtures useful as ultrasound contrast media, contrast agents containing the media and method
US5445813A (en) * 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
AU636481B2 (en) * 1990-05-18 1993-04-29 Bracco International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
IL104084A (en) * 1992-01-24 1996-09-12 Bracco Int Bv Long-lasting aqueous suspensions of pressure-resistant gas-filled microvesicles their preparation and contrast agents consisting of them
US5464696A (en) * 1992-08-13 1995-11-07 Bracco International B.V. Particles for NMR imaging
AU694135B2 (en) * 1993-07-30 1998-07-16 Imcor Pharmaceutical Company Stabilized microbubble compositions for ultrasound
US6333021B1 (en) * 1994-11-22 2001-12-25 Bracco Research S.A. Microcapsules, method of making and their use
IL116328A (en) * 1994-12-16 1999-09-22 Bracco Research Sa Frozen suspension of gas microbubbles in frozen aqueous carrier for use as contrast agent in ultrasonic imaging
US6139819A (en) * 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
TR199801613T2 (xx) * 1996-02-19 1998-11-23 Nycomed Imaging A/S Kontrast ajanlar�nda ya da bunlarla ilgili iyile�tirmeler.
CA2269985A1 (en) * 1996-10-28 1998-05-07 Aslak Godal Improvements in or relating to diagnostic/therapeutic agents
CA2270120A1 (en) * 1996-10-28 1998-05-07 Pal Rongved Improvements in or relating to diagnostic/therapeutic agents
US6416740B1 (en) * 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
ATE296113T1 (de) * 1998-02-09 2005-06-15 Bracco Research Sa Zielgerichtete abgabe von biologische-aktive medien
GB9808599D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or realting to contrast agents
JP2002212108A (ja) * 2001-01-17 2002-07-31 Fuji Photo Film Co Ltd 超音波散乱体
JP2005505532A (ja) * 2001-08-16 2005-02-24 ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー 気体微粒子リポソーム複合体
CN100563718C (zh) * 2003-12-22 2009-12-02 伯拉考开发股份有限公司 用于反差成像的充气微囊组件

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5562099A (en) * 1990-10-05 1996-10-08 Massachusetts Institute Of Technology Polymeric microparticles containing agents for imaging
WO1995023615A1 (en) * 1994-03-01 1995-09-08 Holmes, Michael, John Gas-containing microcapsules useful as contrast agents for diagnostic imaging
US6331289B1 (en) * 1996-10-28 2001-12-18 Nycomed Imaging As Targeted diagnostic/therapeutic agents having more than one different vectors

Also Published As

Publication number Publication date
CN1897978B (zh) 2011-11-23
ES2531751T3 (es) 2015-03-18
NO338317B1 (no) 2016-08-08
CN1897978A (zh) 2007-01-17
CA2545362A1 (en) 2005-07-14
WO2005063306A1 (en) 2005-07-14
US20070081946A1 (en) 2007-04-12
AU2004308757A1 (en) 2005-07-14
NO20063420L (no) 2006-09-22
JP2007515471A (ja) 2007-06-14
CA2545362C (en) 2013-02-12
US20110150778A1 (en) 2011-06-23
EP1696965A1 (en) 2006-09-06
EP1696965B1 (en) 2014-12-10

Similar Documents

Publication Publication Date Title
AU2004308757B2 (en) Assembly of gas-filled microvesicle with active component for contrast imaging
AU2003901146A0 (en) Feedthrough assembly
AU2003902319A0 (en) Laser video detector
AU2003239268A1 (en) Contrast agent imaging with synchronized persistence
AU2003272531A1 (en) Medical imaging systems
AU2003297292A1 (en) Support member for an assembly
AU2003302995A1 (en) Improved airspring assembly
EP1463306B8 (en) Imaging device that prevents loss of shadow detail
AU2003903368A0 (en) Chiller
AU2003251130A1 (en) Inner and outer motor with eccentric stabilizer
AU2003900377A0 (en) Optical assembly
AU2003269212A1 (en) Magnet assembly
AU2003272650A1 (en) Digital rf transceiver with multiple imaging modes
AU2003242614A1 (en) Method for the preparation of halogenated benzonitriles
AU2003298366A1 (en) Telephone-watch with improved acoustics
AU2003272198A1 (en) Storage of blood
AU2003900164A0 (en) Vehicle subwoofer with external field cancellation
AU2003900549A0 (en) An assembly
AU2003295240A1 (en) Microporous structure of an organic metal complex
AU2002258352A1 (en) Stabilizing member of an earphone assembly
AU2003902788A0 (en) Active compounds and uses therefor
HK1094446A (en) Cycloalkyl derivatives of 3-hydroxy-4-pyridinones
HK1123046A (en) Lactam compounds and methods of using the same
AU2003905800A0 (en) An Improved Active Wine Barrel
AU2003901940A0 (en) Video email

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired